Privium Fund Management’s Revelation Biosciences Warrant REVBW Stock Holding History

Privium Fund Management’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-44,000	Closed	-$752	–	118
2024 Q2	$752	Hold	44,000	–	–	﹤0.01%	129
2024 Q1	$1.17K	Hold	44,000	–	–	﹤0.01%	116
2023 Q4	$466	Hold	44,000	–	–	﹤0.01%	113
2023 Q3	$744	Hold	44,000	–	–	﹤0.01%	115
2023 Q2	$880	Hold	44,000	–	–	﹤0.01%	122
2023 Q1	$713	Hold	44,000	–	–	﹤0.01%	124
2022 Q4	$497	Hold	44,000	–	–	﹤0.01%	144
2022 Q3	$2K	Hold	44,000	–	–	﹤0.01%	188
2022 Q2	$4K	Hold	44,000	–	–	﹤0.01%	200
2022 Q1	$6K	Hold	44,000	–	–	﹤0.01%	257
2021 Q4	$29K	Buy	+44,000	New	+$27K	0.01%	184

Other funds holding REVBW

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Privium Fund Management's REVBW Position: Q3 2024 in Review

Privium Fund Management sold out of Revelation Biosciences Warrant (REVBW) in Q3 2024, closing a stake of 44,000 shares — an estimated $752 sold.

Privium Fund Management first reported a position in REVBW in Q4 2021 and held it in 11 quarters. The position peaked at $29K in Q4 2021. 13 funds tracked by Wall St. Rank hold REVBW as of Q3 2024.

Privium Fund Management reported no remaining Revelation Biosciences Warrant position as of Q3 2024 after selling out during the quarter.
Privium Fund Management sold 44,000 Revelation Biosciences Warrant shares in Q3 2024, an estimated $752.
Privium Fund Management first reported a position in Revelation Biosciences Warrant in Q4 2021 and held it in 11 quarters.
Privium Fund Management's Revelation Biosciences Warrant position peaked at $29K in Q4 2021.
13 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q3 2024.

Based on Privium Fund Management's 13F filing for Q3 2024, filed 1 Nov 2024.